SIRT1 inhibits gastric cancer proliferation and metastasis via STAT3/MMP‐13 signaling
Authors:
- 2 February 2019
- journal article
- research article
- Published by Wiley in Journal of Cellular Physiology
- Vol. 234 (9) , 15395-15406
Abstract
Gastric cancer prognoses are persistently poor due to cancer's penchant to metastasize. As a crucial regulator of signal transducer and activator of transcription (STAT3) signaling, sirtuin 1's (SIRT1) function in gastric cancer has not been well understood. Here, we report upregulated expression of SIRT1 in tissues isolated from gastric cancer patients. However, we show that the depletion of SIRT1‐mediated enhanced cancer cell proliferation and metastasis, and resulted in the enrichment of phosphorylated STAT3, acetylated STAT3, and matrix metalloproteinase 13 (MMP‐13) in both in vivo and in vitro experiments. Additionally, we demonstrate that small interfering RNAs targeting the production of STAT3, AG490, and CL‐821983 in cancer cells depleted of SIRT1 reduce metastasis. Our findings indicate that MMP‐13 expression is associated with lymph node metastasis and poor survival outcomes in gastric cancer patients. In vivo models also showed that depleted SIRT1 promoted gastric cancer growth via the STAT3/MMP‐13 axis. In conclusion, SIRT1 depletion encourages gastric cancer progression through the activation of STAT3/MMP‐13 signaling, suggesting that SIRT1 may function as a tumor suppressor. We postulate that the upregulation of SIRT1 in gastric cancer patients may be the result of a feedback mechanism that aims to oppose the damaging effects of STAT3 signaling. As such, SIRT1 activators could potentially serve as preventive and therapeutic treatments for metastatic gastric cancer.Keywords
Funding Information
- National Natural Science Foundation of China (81272742, 81802396, 81672935, 81401977)
- Natural Science Foundation of Jiangsu Province (BK20180117)
This publication has 27 references indexed in Scilit:
- SIRT1 promotes epithelial–mesenchymal transition and metastasis in colorectal cancer by regulating Fra-1 expressionCancer Letters, 2016
- Low nanomolar concentrations of Cucurbitacin-I induces G2/M phase arrest and apoptosis by perturbing redox homeostasis in gastric cancer cells in vitro and in vivoCell Death & Disease, 2016
- Assessing sirtuin expression in endometrial carcinoma and non-neoplastic endometriumOncotarget, 2015
- Differences in Clinicopathology of Early Gastric Carcinoma between Proximal and Distal Location in 438 Chinese PatientsScientific Reports, 2015
- Sirtuin 1 Is a Negative Regulator of Parathyroid Hormone Stimulation of Matrix Metalloproteinase 13 Expression in Osteoblastic CellsJournal of Biological Chemistry, 2015
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012International Journal of Cancer, 2014
- Matrix metalloproteinase‐9 is associated with disease‐free survival and overall survival in patients with gastric cancerInternational Journal of Cancer, 2010
- Expression of DBC1 and SIRT1 Is Associated with Poor Prognosis of Gastric CarcinomaClinical Cancer Research, 2009
- Matrix metalloproteinases and tumor metastasisCancer and Metastasis Reviews, 2006
- New functions for the matrix metalloproteinases in cancer progressionNature Reviews Cancer, 2002